SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 72 filers reported holding SURFACE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,104 | +24.9% | 10,450 | 0.0% | 0.00% | – |
| Q1 2023 | $7,288 | -19.0% | 10,450 | -14.0% | 0.00% | – |
| Q4 2022 | $9,000 | -30.8% | 12,155 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -35.0% | 12,155 | +0.8% | 0.00% | – |
| Q2 2022 | $20,000 | -89.0% | 12,055 | +5.1% | 0.00% | – |
| Q1 2022 | $181,000 | +206.8% | 11,466 | -7.3% | 0.00% | – |
| Q4 2021 | $59,000 | -55.3% | 12,366 | -28.9% | 0.00% | – |
| Q3 2021 | $132,000 | +11.9% | 17,396 | +9.9% | 0.00% | – |
| Q2 2021 | $118,000 | +100.0% | 15,835 | +107.4% | 0.00% | – |
| Q1 2021 | $59,000 | +110.7% | 7,635 | +152.6% | 0.00% | – |
| Q4 2020 | $28,000 | +86.7% | 3,022 | +39.1% | 0.00% | – |
| Q3 2020 | $15,000 | +36.4% | 2,172 | +29.9% | 0.00% | – |
| Q2 2020 | $11,000 | – | 1,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |